WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8

NCT01659437 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

310

Enrollment

OTHER

Sponsor class

Conditions

Mycobacterium Ulcerans Infection

Interventions

DRUG: Clarithromycin Extended Release
DRUG: Streptomycin intramuscular injection

Sponsor

University Medical Center Groningen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]